drugset / Trial / NCT07319585

Managed Access Programs for EXV811, Atrasentan

NCT07319585

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to EXV811, Atrasentan

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Atrasentan Other / unclassified